Targeting MRS-Defined Dominant Intraprostatic Lesions with Inverse-Planned High Dose Rate Brachytherapy
Abstract
During this first year, we have obtained CHR approval (December 2004) from the three step process (C.U., P.R.C. and C.H.R.) committees at UCSF. Patient enrollment will begin immediately after receiving CHR approval from D.O.D. The accuracy of aligning MRI/MSRI data acquired with different types of endorectal probes to images acquired without a probe was determined. A 94% Average overlap of prostate contours was obtained using rigid endorectal coil. We have also obtained a class solution for the boost of DIL defined by MRI/MRST and the maximum achievable boost level under clinical dosimetric requirements using data from 10 previously treated HDR brachytherapy patients.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 01, 2005
- Accession Number
- ADA447537
Entities
People
- I-chow Hsu
- Jean Pouliot
- John Kurhanewicz
- Sue Noworelski
Organizations
- University of California, San Francisco